Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

13.33
-0.4900-3.55%
Post-market: 13.430.1000+0.75%19:59 EDT
Volume:2.08M
Turnover:28.33M
Market Cap:1.84B
PE:-3.69
High:14.02
Open:13.82
Low:13.30
Close:13.82
52wk High:15.40
52wk Low:4.29
Shares:138.00M
Float Shares:107.00M
Volume Ratio:0.92
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6118
EPS(LYR):-3.0800
ROE:-319.07%
ROA:-29.08%
PB:21.76
PE(LYR):-4.33

Loading ...

Compass Pathways PLC expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
May 11

EXE, IP, ESPR, CMPS, TNXP Trending With Analysts

TIPRANKS
·
May 09

Earning Preview: COMPASS Pathways plc this quarter’s revenue is expected to increase by 0%, and institutional views are mostly bullish

Earnings Agent
·
May 07

Press Release: Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026

Dow Jones
·
May 06

Compass Pathways to report Q1 results, hosts conference call

Reuters
·
May 06

Compass Pathways grants 125,335 inducement stock options at $9.01 per share

Reuters
·
May 06

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 06

COMPASS Pathways (CMPS) Is Up 7.1% After FDA Priority Status For COMP360 Psilocybin Therapy

Simply Wall St.
·
May 05

Compass Pathways Initiated at Buy by Jefferies

Dow Jones
·
May 05

Compass Pathways PLC expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
May 04

Jefferies & Co Initiates Coverage on COMPASS Pathways With Buy Rating, $18 Price Target

MT Newswires Live
·
May 04

Compass Pathways Plc : Jefferies Initiates Coverage With Buy Rating; Target Price $18

THOMSON REUTERS
·
May 04

Compass Pathways initiated with a Buy at Jefferies

TIPRANKS
·
May 04

Compass Pathways Price Target Maintained With a $70.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 28

How Investors May Respond To COMPASS Pathways (CMPS) FDA Priority Review Path For Psilocybin Therapy

Simply Wall St.
·
Apr 27

LifeSci Capital Sticks to Its Buy Rating for COMPASS Pathways (CMPS)

TIPRANKS
·
Apr 26

FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit. -- Barrons.com

Dow Jones
·
Apr 25

What's Going On With Enveric Biosciences Stock On Friday?

Benzinga
·
Apr 25

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Compass Pathways, Charter Communications

Reuters
·
Apr 25

BRIEF-Compass Pathways Says FDA Granted NDA Rolling Review Request & Awarded Commissioner's National Priority Voucher

Reuters
·
Apr 25